Dec. 6, 2012
/PRNewswire/ -- BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today that it has been selected as a Top 100 Winner for
's 2012 Global Award in recognition as a leader in innovation and technology among private companies from
's Top 100 Global list has become a mark of distinction for identifying promising new companies and entrepreneurs.
"Choosing the companies with the strongest potential was by no means a small feat," said
, publisher and CEO of
. "After rigorous contemplation and discussion, we narrowed our list down from hundreds of Global candidates to the Top 100 Winners. We believe BONESUPPORT embodies the vision, drive and innovation that define a successful entrepreneurial venture. BONESUPPORT should be proud of its accomplishment, as the competition was the strongest it has ever been."
's editorial staff evaluated the companies on both quantitative and qualitative criteria, such as financial performance, technology innovation, management quality, strategy, and market penetration. This assessment of potential is complemented by a review of the track record and standing of startups relative to their peers, allowing
to see past the "buzz" and make the list a valuable instrument of discovery and advocacy for the most promising new business models from around the world.
"This is a great distinction for BONESUPPORT as we continue to focus our efforts on global commercialization of our platform technology CERAMENT™," said
, CEO of BONESUPPORT. "This award will help to further build awareness of our innovative technology and I am pleased that we have been recognized in this way."